Back to companies

Enanta Pharmaceuticals Inc: Overview

Enanta Pharmaceuticals Inc (Enanta) is a clinical-stage biotechnology company that develops small molecule drugs for viral infections. The company’s pipeline includes glecaprevir, EDP-514, EDP-938, EDP-323, EDP-235, EDP-305, EDP - 297.h Its pipeline candidates treat hepatitis C virus (HCV), Hepatitis B virus (HBV), respiratory syncytial virus (RSV), COVID-19 and non-alcoholic steatohepatitis (NASH). Its brands include Mavyret and Vieira pak. The company works in partnership with the National Institute of Allergy and Infectious Diseases, AbbVie Inc, Novartis, Shionogi Inc to discover two protease inhibitor compounds. Enanta is headquartered in Watertown, Massachusetts, the US.

Gain a 360-degree view of Enanta Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Enanta Pharmaceuticals Inc and make more informed decisions for your business Contact Us
Headquarters United States of America

Address 500 Arsenal Street, Watertown, Massachusetts, 02472


Telephone 1 617 6070800

No of Employees 145

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange ENTA (NASD)

Revenue (2023) $79.2M

EPS XYZ

Market Cap* $300.6M

Net Profit Margin (2023) XYZ -19.6%

   

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

Enanta Pharmaceuticals Inc premium industry data and analytics

60+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Enanta Pharmaceuticals Inc’s relevant decision makers and contact details.

50+

Catalyst Calendar

Proactively evaluate Enanta Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

40+

Clinical Trials

Determine Enanta Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

30+

Pipeline Drugs

Identify which of Enanta Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

9

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Enanta Pharmaceuticals Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Glecaprevir - Hepatitis C Virus (HCV) MAVYRET
EDP-514 - Hepatitis B virus (HBV) VIEKIRA PAK
EDP-938- Respiratory Syncytial Virus (RSV)
XYZ
XYZ
XYZ
Understand Enanta Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand Enanta Pharmaceuticals Inc portfolio and identify potential areas for collaboration Contact Us
Image for loader

Competitor Comparison

Key Parameters Enanta Pharmaceuticals Inc DMK Pharmaceuticals Corp Axim Biotechnologies Inc Eledon Pharmaceuticals Inc Global Life Sciences Solutions USA LLC
Headquarters United States of America United States of America United States of America United States of America United States of America
City Watertown San Diego San Diego Irvine Marlborough
State/Province Massachusetts California California California Massachusetts
No. of Employees 145 11 6 17 10,000
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Contact Us
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Contact Us
Executives
Name Position Board Since Age
Bruce L.A. Carter Chairman Executive Board 2015 79
Jay R. Luly President; Chief Executive Officer; Director Executive Board 2003 66
Paul J. Mellett Senior Vice President - Finance and Administration; Chief Financial Officer Senior Management 2003 67
Scott T. Rottinghaus Senior Vice President; Chief Medical Officer Senior Management 2022 49
Yat Sun Or, Ph.D. Chief Scientific Officer; Senior Vice President - Research and Development Senior Management 1999 71
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Enanta Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Enanta Pharmaceuticals Inc key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward